Quarterly Result14 Aug 2026, 08:24 pm
Samrat Pharmachem declares Q1 FY27 unaudited standalone results
AI Summary
Samrat Pharmachem Limited announced its unaudited standalone financial results for the quarter ended June 30, 2026. The Board of Directors considered and adopted these results during a meeting held on August 14, 2026. The company manufactures pharmaceutical chemicals and operates in a single business segment. The results were reviewed by the Audit Committee and the Statutory Auditor provided a Limited Review Report.
Key Highlights
- Board adopted unaudited standalone financial results for Q1 FY27.
- Results for the quarter ended June 30, 2026, were considered.
- Company operates in the pharmaceutical chemicals segment.
- Limited Review Report from Statutory Auditor is enclosed.
- Results reviewed by the Audit Committee.
Price Impact
More from SAMRATPH